Karen Lambie

579 total citations
12 papers, 406 citations indexed

About

Karen Lambie is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Karen Lambie has authored 12 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Karen Lambie's work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Karen Lambie is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Karen Lambie collaborates with scholars based in Canada, France and United Kingdom. Karen Lambie's co-authors include Connie J. Eaves, Tessa L. Holyoake, Allen Eaves, Andreas Petzer, Xiaoyan Jiang, Emily M. Pang, Johanne D. Cashman, Franck E. Nicolini, Peter M. Lansdorp and Donna E. Hogge and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Karen Lambie

12 papers receiving 392 citations

Peers

Karen Lambie
Doan Le Canada
Ciro R. Rinaldi United Kingdom
Monika J. Stankiewicz United States
RP Castleberry United States
Lemlem Alemu United States
RS Neiman United States
Doan Le Canada
Karen Lambie
Citations per year, relative to Karen Lambie Karen Lambie (= 1×) peers Doan Le

Countries citing papers authored by Karen Lambie

Since Specialization
Citations

This map shows the geographic impact of Karen Lambie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Lambie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Lambie more than expected).

Fields of papers citing papers by Karen Lambie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Lambie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Lambie. The network helps show where Karen Lambie may publish in the future.

Co-authorship network of co-authors of Karen Lambie

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Lambie. A scholar is included among the top collaborators of Karen Lambie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Lambie. Karen Lambie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sloma, Ivan, Philip Beer, Christophe Desterke, et al.. (2020). Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression. Haematologica. 106(3). 881–885. 1 indexed citations
2.
Sloma, Ivan, Philip Beer, Christophe Desterke, et al.. (2019). NUP98-HOXA9-Initiates Molecular and Biologic Features of Disease Progression in a Humanized Model of CML. Blood. 134(Supplement_1). 4139–4139. 1 indexed citations
3.
Sloma, Ivan, Philip Beer, Kyi Min Saw, et al.. (2013). Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia. Experimental Hematology. 41(10). 837–847. 9 indexed citations
4.
Sloma, Ivan, Suzan Imren, Philip Beer, et al.. (2012). Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene. Leukemia. 27(1). 159–169. 13 indexed citations
5.
Law, Jennifer, Yvonne Li, Karen To, et al.. (2010). Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability. PLoS ONE. 5(9). e12661–e12661. 43 indexed citations
6.
Jiang, Xiaoyan, Donna L. Forrest, Franck E. Nicolini, et al.. (2010). Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate. Blood. 116(12). 2112–2121. 46 indexed citations
7.
Goldman, Frederick D., Geraldine Aubert, Aloysius J. Klingelhutz, et al.. (2008). Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita. Blood. 111(9). 4523–4531. 42 indexed citations
8.
Eisterer, Wolfgang, Xiaoyan Jiang, Oliver Christ, et al.. (2005). Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Leukemia. 19(3). 435–441. 104 indexed citations
9.
Hennemann, B., Jean Y. Chuo, P Schley, et al.. (2000). High-Efficiency Retroviral Transduction of Mammalian Cells on Positively Charged Surfaces. Human Gene Therapy. 11(1). 43–51. 23 indexed citations
10.
Hogge, Donna E., Karen Lambie, HJ Sutherland, et al.. (2000). Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant. Bone Marrow Transplantation. 25(6). 589–598. 14 indexed citations
11.
Nicolini, Franck E., et al.. (1999). Unique Differentiation Programs of Human Fetal Liver Stem Cells Shown Both In Vitro and In Vivo in NOD/SCID Mice. Blood. 94(8). 2686–2695. 60 indexed citations
12.
Hogge, Donna E., Andreas Petzer, Karen Lambie, et al.. (1997). Quantitation and characterization of human megakaryocyte colony‐forming cells using a standardized serum‐free agarose assay. British Journal of Haematology. 96(4). 790–800. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026